atex-20220329x8k

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
‎Pursuant to Section 13 OR 15(d) of
‎The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 29, 2022

Anterix Inc.

(Exact name of registrant as specified in its charter)


Delaware	001-36827	33-0745043
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification No.)

3 Garret Mountain Plaza

Suite 401

Woodland Park, NJ

07424

(Address of principal executive offices)

(Zip Code)

(973) 771-0300
‎Registrant’s telephone number, including area code

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading symbol	Name of Each Exchange on which registered
Common Stock, $0.0001 par value	ATEX	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 25, 2022, Hamid Akhavan delivered notice to the board of directors (the “Board”) of Anterix Inc. (the “Company”) of his resignation from the Board, effective April 1, 2022, following his appointment as the Chief Executive Officer and President of EchoStar Corporation, also effective April 1, 2022. Mr. Akhavan also resigned from his membership on the Nominating and Corporate Governance Committee and the Compensation Committee. The resignation is not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

‎

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.


	Anterix Inc.


Date: March 29, 2022	/s/ Gena L. Ashe
	Gena L. Ashe
	Chief Legal Officer and Corporate Secretary

Anterix Inc. filed SEC Form 8-K: Leadership Update